Related Experiment Videos

[Epilepsy and learning disorders]

R Archila1

  • 1Universidad Central de Venezuela, Caracas, Venezuela. jmariete@canto.net

Revista De Neurologia
|September 29, 2000
PubMed

Insights

Children with epilepsy experience more behavioral and cognitive issues due to seizures, genetics, and treatments. Antiepileptic drugs, especially in combination, can impact neurobehavioral outcomes.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Child Psychology

Background:

  • Children with epilepsy exhibit higher rates of behavioral and cognitive problems compared to healthy peers and those with other chronic illnesses.
  • Key risk factors include seizure activity, familial and child-specific variables, and frequently unrecognized behavioral issues like depression.
  • Anxiety disorders and psychoses are less prevalent but still significant concerns in this population.

Purpose of the Study:

  • To explore the multifactorial nature of learning and behavioral challenges in children with epilepsy.
  • To investigate the impact of epilepsy itself and its treatment modalities on neurobehavioral outcomes.
  • To highlight the neurobehavioral effects of antiepileptic drugs, particularly in polypharmacy.

Main Methods:

  • Review of literature on the neurobehavioral aspects of childhood epilepsy.
  • Analysis of the etiological factors contributing to cognitive and behavioral deficits.
  • Examination of the influence of seizure activity, underlying conditions, and therapeutic interventions.

Main Results:

  • Epilepsy and its underlying causes significantly impact children's cognitive and behavioral development.
  • Seizure activity, through metabolic and excitatory effects, alters nervous system function.
  • Pharmacological and surgical treatments for epilepsy can adversely affect cognitive functions.

Conclusions:

  • The neurobehavioral effects of antiepileptic drugs (AEDs) are a critical consideration in managing childhood epilepsy.
  • While newer AEDs may have reduced impact, polypharmacy remains a concern for potential adverse neurobehavioral outcomes.
  • Ongoing monitoring for and management of neurobehavioral issues are essential for children with epilepsy.
Abstract

Related Concept Videos